This week, the peer-reviewed science publisher Sage Journals retracted three controversial abortion studies, two of which have been frequently cited by plaintiffs in an upcoming case that could restrict access to the abortion pill nationwide.
One study, published in the journal Health Services Research and Managerial Epidemiology in 2021, claimed that mifepristone — one of two pills used in a medication abortion — increased the risk of women going to the emergency room following a medication abortion compared to surgical abortions. The second study concluded that people who go to the emergency room after taking mifepristone are frequently misclassified as miscarriages, suggesting that mifepristone complications are wrongfully being concealed.
